Rituximab in the Management of a Child with Pemphigus Vulgaris: Case Study
Background. Pemphigus vulgaris is an autoimmune bullous dermatosis. Its management generally involves lifelong administration of maintenance dose of systemic glucocorticosteroids, that leading to serious adverse effects especially in children.Clinical case description. Patient is the 16 years old bo...
Saved in:
| Main Authors: | Nikolay N. Murashkin, Leonid A. Opryatin, Anastasiya A. Vasilenko, Eduard T. Ambarchian, Roman V. Epishev, Alexander I. Materikin, Roman A. Ivanov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2022-11-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/3037 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low Dose Vs Conventional Rituximab Regimen in Pemphigus Vulgaris – A Retrospective Single Centre Comparative Analysis to Assess the Clinical Efficacy and Cost-Effectiveness
by: Amuthavalli Kanagarajan, et al.
Published: (2025-07-01) -
Assessment of Efficacy of Adjuvant Topical Rituximab Encapsulated in Nanoparticle Gel in Oral Pemphigus Vulgaris: A Randomized, Double-Blind, Placebo-Controlled, Pilot Study
by: Pratik Rajendra Mohta, et al.
Published: (2025-07-01) -
Characteristics and management of pediatric pemphigus vulgaris
by: LIANG Wenhui, CHEN Yuting, DAN Hongxia
Published: (2025-07-01) -
Dupilumab as Immunomodulatory Rescue for Severe Recalcitrant Pemphigus Vulgaris: A Case Report and Literature Review
by: Boonpethkaew S, et al.
Published: (2025-07-01) -
Clinical Features, Diagnosis and Treatment of Different Types of Paediatric Pemphigus
by: An-Wei Chen, et al.
Published: (2025-03-01)